Movatterモバイル変換


[0]ホーム

URL:


AU2003222068A1 - Improved methods for achieving expression from alphavirus vectors - Google Patents

Improved methods for achieving expression from alphavirus vectors

Info

Publication number
AU2003222068A1
AU2003222068A1AU2003222068AAU2003222068AAU2003222068A1AU 2003222068 A1AU2003222068 A1AU 2003222068A1AU 2003222068 AAU2003222068 AAU 2003222068AAU 2003222068 AAU2003222068 AAU 2003222068AAU 2003222068 A1AU2003222068 A1AU 2003222068A1
Authority
AU
Australia
Prior art keywords
improved methods
alphavirus vectors
achieving expression
achieving
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003222068A
Other versions
AU2003222068A8 (en
Inventor
Robert E. Johnston
William B. Klimstra
Kate D. Ryman
Jiagang Wang
Laura J. White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Original Assignee
University of North Carolina at Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel HillfiledCriticalUniversity of North Carolina at Chapel Hill
Publication of AU2003222068A8publicationCriticalpatent/AU2003222068A8/en
Publication of AU2003222068A1publicationCriticalpatent/AU2003222068A1/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU2003222068A2002-03-252003-03-25Improved methods for achieving expression from alphavirus vectorsAbandonedAU2003222068A1 (en)

Applications Claiming Priority (5)

Application NumberPriority DateFiling DateTitle
US36777602P2002-03-252002-03-25
US36789302P2002-03-252002-03-25
US60/367,7762002-03-25
US60/367,8932002-03-25
PCT/US2003/009121WO2003083065A2 (en)2002-03-252003-03-25Improved methods for achieving expression from alphavirus vectors

Publications (2)

Publication NumberPublication Date
AU2003222068A8 AU2003222068A8 (en)2003-10-13
AU2003222068A1true AU2003222068A1 (en)2003-10-13

Family

ID=28678198

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU2003222068AAbandonedAU2003222068A1 (en)2002-03-252003-03-25Improved methods for achieving expression from alphavirus vectors

Country Status (2)

CountryLink
AU (1)AU2003222068A1 (en)
WO (1)WO2003083065A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE60233061D1 (en)2001-09-062009-09-03Alphavax Inc ALPHAVIRUS REPLICON VECTOR SYSTEMS
KR101518309B1 (en)2003-03-202015-05-08알파벡스, 인크.Improved alphavirus replicons and helper constructs
DK1651666T3 (en)2003-07-112009-08-31Alphavax Inc Alphavirus-based cytomegalovirus vaccines
AU2005327198B2 (en)2004-07-092011-03-31University Of North Carolina At Chapel HillViral adjuvants
EP1856250B1 (en)2005-02-152013-07-24The University of North Carolina At Chapel HillNew live virus vaccines
ES2304880B1 (en)*2007-04-032009-10-27Proyecto De Biomedicina Cima, S.L. USE OF A MUTED VIRAL VECTOR FOR THE IN VITRO GENERATION OF STABLE CELLULAR LINES.
ES2670813T3 (en)2007-06-212018-06-01Alphavax, Inc. Alphavirus Replicon Particles for Vaccination Use
GB201310432D0 (en)*2013-06-122013-07-24Univ St AndrewsVirus Production
US10494421B2 (en)2014-02-102019-12-03Univercells NvSystem, apparatus and method for biomolecules production
WO2020056228A1 (en)*2018-09-142020-03-19Mayo Foundation For Medical Education And ResearchMaterials and methods for treatment with oncolytic viruses and modified car t cells
JP2022512912A (en)*2018-11-072022-02-07グリットストーン バイオ インコーポレイテッド Alpha virus nascent antigen vector and interferon inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6015686A (en)*1993-09-152000-01-18Chiron Viagene, Inc.Eukaryotic layered vector initiation systems

Also Published As

Publication numberPublication date
AU2003222068A8 (en)2003-10-13
WO2003083065A3 (en)2004-07-29
WO2003083065A2 (en)2003-10-09

Similar Documents

PublicationPublication DateTitle
AU2002334717A1 (en)Improved method for generating an aerosol
AU2003221733A1 (en)Improved raav vectors
AU2003222544A1 (en)Homing process
AU2003286006A1 (en)Cyclotron
AU2002232187A1 (en)Authenticating method
AU2003237038A1 (en)Adaptive rate matching method
AU2003206898A1 (en)Method for rate matching
AU2003260951A1 (en)Region restrictive playback system
AU2003241332A1 (en)Keymat
AU2003301899A1 (en)Member for producing castings
AU2003258070A1 (en)Electrodionization method
AU2003222068A1 (en)Improved methods for achieving expression from alphavirus vectors
AU2003278355A1 (en)Process
AU2003301316A1 (en)Improved immunotherapy
AU2003299732A1 (en)Vectors for inducible rna interference
AU2002950473A0 (en)Expression system
AU2003229646A1 (en)Authentication method
AU2003271883A1 (en)Vector system
AU2003264722A1 (en)Methods
AU2003217765A1 (en)System for hair removal
AU2003253813A1 (en)Method for colpoplasty
AU2003253447A1 (en)Expression vectors
AU2003257434A1 (en)L-amidase from rhizobium huautlense
AU2003263197A1 (en)Process
AU2003242061A1 (en)Method for fast frequency estimation by means of the rls method

Legal Events

DateCodeTitleDescription
MK6Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

[8]ページ先頭

©2009-2025 Movatter.jp